128 related articles for article (PubMed ID: 30443295)
21. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
22. Correction:
Contis-Montes de Oca A; Rodarte-Valle E; Rosales-Hernández MC; Abarca-Rojano E; Rojas-Hernández S; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Vázquez-Moctezuma I; Correa-Basurto J
Oncotarget; 2019 Feb; 10(11):1225. PubMed ID: 30838095
[TBL] [Abstract][Full Text] [Related]
23. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
[TBL] [Abstract][Full Text] [Related]
24. Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.
Valentini D; Rao M; Meng Q; von Landenberg A; Bartek J; Sinclair G; Paraschoudi G; Jäger E; Harvey-Peredo I; Dodoo E; Maeurer M
Oncotarget; 2018 Dec; 9(95):36817. PubMed ID: 30613370
[TBL] [Abstract][Full Text] [Related]
25. Correction: MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment.
Yuan H; Wang X; Lu J; Zhang Q; Brandina I; Alexandrov I; Glazer RI
Oncotarget; 2018 Dec; 9(102):37808. PubMed ID: 30701035
[TBL] [Abstract][Full Text] [Related]
26. Correction: Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.
Qiao A; Wang K; Yuan Y; Guan Y; Ren X; Li L; Chen X; Li F; Chen AF; Zhou J; Yang JM; Cheng Y
Oncotarget; 2018 Jun; 9(43):27318. PubMed ID: 29930768
[TBL] [Abstract][Full Text] [Related]
27. Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells.
Fernandez-Carrascal A; Garcia-Algar M; Nazarenus M; Torres-Nuñez A; Guerrini L; Feliu N; Parak WJ; Garcia-Rico E; Alvarez-Puebla RA
Oncotarget; 2019 Nov; 10(61):6643. PubMed ID: 31762944
[TBL] [Abstract][Full Text] [Related]
28. Correction: MiR-451 as a new tumor marker for gastric cancer.
Shen Y; Gong JM; Zhou LL; Sheng JH
Oncotarget; 2019 Oct; 10(59):6396. PubMed ID: 31695848
[TBL] [Abstract][Full Text] [Related]
29. Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.
Hideshima T; Mazitschek R; Qi J; Mimura N; Tseng JC; Kung AL; Bradner JE; Anderson KC
Oncotarget; 2021 Aug; 12(17):1736. PubMed ID: 34434504
[TBL] [Abstract][Full Text] [Related]
30. Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.
Kim S; Tiedt R; Loo A; Horn T; Delach S; Kovats S; Haas K; Engstler BS; Cao A; Pinzon-Ortiz M; Mulford I; Acker MG; Chopra R; Brain C; Tomaso ED; Sellers WR; Caponigro G
Oncotarget; 2020 Apr; 11(14):1289. PubMed ID: 32292577
[TBL] [Abstract][Full Text] [Related]
31. Correction: Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.
Yin SY; Efferth T; Jian FY; Chen YH; Liu CI; Wang AHJ; Chen YR; Hsiao PW; Yang NS
Oncotarget; 2018 Aug; 9(63):32271. PubMed ID: 30181816
[TBL] [Abstract][Full Text] [Related]
32. Correction: Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.
Kim JY; Han JH; Park G; Seo YW; Yun CW; Lee BC; Bae J; Moon AR; Kim TH
Oncotarget; 2018 Jun; 9(42):26977. PubMed ID: 29928495
[TBL] [Abstract][Full Text] [Related]
33. Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Al-Jameel W; Gou X; Forootan SS; Fayi MSA; Rudland PS; Forootan FS; Zhang J; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2020 Aug; 11(31):3025. PubMed ID: 32821347
[TBL] [Abstract][Full Text] [Related]
34. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
[TBL] [Abstract][Full Text] [Related]
35. Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2018 Dec; 9(102):37807. PubMed ID: 30701034
[TBL] [Abstract][Full Text] [Related]
36. Correction: Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.
Terlizzi M; Colarusso C; De Rosa I; De Rosa N; Somma P; Curcio C; Sanduzzi A; Micheli P; Molino A; Saccomanno A; Salvi R; Aquino RP; Pinto A; Sorrentino R
Oncotarget; 2018 Jun; 9(50):29537. PubMed ID: 30034638
[TBL] [Abstract][Full Text] [Related]
37. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
[TBL] [Abstract][Full Text] [Related]
38. Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.
Novohradsky V; Zajac J; Vrana O; Kasparkova J; Brabec V
Oncotarget; 2018 Oct; 9(85):35599. PubMed ID: 30473754
[TBL] [Abstract][Full Text] [Related]
39. Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2018 Apr; 9(25):17979. PubMed ID: 29707163
[TBL] [Abstract][Full Text] [Related]
40. Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
Oncotarget; 2019 Feb; 10(16):1602. PubMed ID: 30899428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]